NYC-based Precision Neuroscience, co-founded by a Neuralink co-founder to create a less invasive brain implant to track diseases, raised a $41M Series B

bloomberg.com/tosv2.html?url=L25ld3MvYXJ0aWNsZXMvMjAyMy0wMS0yNS9leC1leGVjdXRpdmUtYXQtZWxvbi1tdXNrLXMtbmV1cmFsaW5rLXJhaXNlcy00MS1taWxsaW9uLWZvci1uZXctYnJhaW4tc3RhcnR1cA%3D%3D&uuid=b4cbbaed-9cb2-11ed-8ca3-6d47796a7370&vid=